172 related articles for article (PubMed ID: 28665924)
1. Somatic PIK3CA mutations are present in multiple tissues of facial infiltrating lipomatosis.
Couto JA; Konczyk DJ; Vivero MP; Kozakewich HPW; Upton J; Fu X; Padwa BL; Mulliken JB; Warman ML; Greene AK
Pediatr Res; 2017 Nov; 82(5):850-854. PubMed ID: 28665924
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA mutations in lipomatosis of nerve with or without nerve territory overgrowth.
Blackburn PR; Milosevic D; Marek T; Folpe AL; Howe BM; Spinner RJ; Carter JM
Mod Pathol; 2020 Mar; 33(3):420-430. PubMed ID: 31481664
[TBL] [Abstract][Full Text] [Related]
3. PIK3CA activating mutations in facial infiltrating lipomatosis.
Maclellan RA; Luks VL; Vivero MP; Mulliken JB; Zurakowski D; Padwa BL; Warman ML; Greene AK; Kurek KC
Plast Reconstr Surg; 2014 Jan; 133(1):12e-19e. PubMed ID: 24374682
[TBL] [Abstract][Full Text] [Related]
4. Delineation of the phenotypes and genotypes of facial infiltrating lipomatosis associated with PIK3CA mutations.
Chen H; Sun B; Gao W; Qiu Y; Hua C; Lin X
Orphanet J Rare Dis; 2023 Jul; 18(1):189. PubMed ID: 37452404
[TBL] [Abstract][Full Text] [Related]
5. Congenital infiltrating lipomatosis of the face with lingual mucosal neuromas associated with a PIK3CA mutation.
Briand C; Galmiche-Rolland L; Vabres P; Couloigner V; Audebert S; Misery L; Abasq-Thomas C
Pediatr Dermatol; 2020 Nov; 37(6):1128-1130. PubMed ID: 32770747
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and surgical management of facial infiltrating lipomatosis: a single center experience.
Chen H; Sun B; Xia W; Qiu Y; Gao W; Hua C; Lin X
Head Face Med; 2024 Feb; 20(1):13. PubMed ID: 38378686
[TBL] [Abstract][Full Text] [Related]
7. Somatic mosaicism for the p.His1047Arg mutation in PIK3CA in a girl with mesenteric lipomatosis.
Cohen AS; Townsend KN; Xiang QS; Attariwala R; Borchers C; Senger C; Picker W; Levi J; Yewchuk L; Tan J; Eydoux P; Lum A; Yong SL; McKinnon ML; Lear SA; Everett R; Jones SJ; Yip S; Gibson WT
Am J Med Genet A; 2014 Sep; 164A(9):2360-4. PubMed ID: 24903541
[TBL] [Abstract][Full Text] [Related]
8. Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants.
Goss JA; Konczyk DJ; Smits P; Sudduth CL; Bischoff J; Liang MG; Greene AK
Clin Genet; 2020 May; 97(5):736-740. PubMed ID: 31909475
[TBL] [Abstract][Full Text] [Related]
9. Causal somatic mutations in urine DNA from persons with the CLOVES subgroup of the PIK3CA-related overgrowth spectrum.
Michel ME; Konczyk DJ; Yeung KS; Murillo R; Vivero MP; Hall AM; Zurakowski D; Adams D; Gupta A; Huang AY; Chung BHY; Warman ML
Clin Genet; 2018 May; 93(5):1075-1080. PubMed ID: 29231959
[TBL] [Abstract][Full Text] [Related]
10. The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS).
Suzuki Y; Enokido Y; Yamada K; Inaba M; Kuwata K; Hanada N; Morishita T; Mizuno S; Wakamatsu N
Oncotarget; 2017 Jul; 8(28):45470-45483. PubMed ID: 28525374
[TBL] [Abstract][Full Text] [Related]
11. Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America.
Garneau AP; Haydock L; Tremblay LE; Isenring P
J Mol Med (Berl); 2021 Mar; 99(3):311-313. PubMed ID: 33392635
[No Abstract] [Full Text] [Related]
12. Facial infiltrating lipomatosis.
Padwa BL; Mulliken JB
Plast Reconstr Surg; 2001 Nov; 108(6):1544-54. PubMed ID: 11711926
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing.
Kuentz P; St-Onge J; Duffourd Y; Courcet JB; Carmignac V; Jouan T; Sorlin A; Abasq-Thomas C; Albuisson J; Amiel J; Amram D; Arpin S; Attie-Bitach T; Bahi-Buisson N; Barbarot S; Baujat G; Bessis D; Boccara O; Bonnière M; Boute O; Bursztejn AC; Chiaverini C; Cormier-Daire V; Coubes C; Delobel B; Edery P; Chehadeh SE; Francannet C; Geneviève D; Goldenberg A; Haye D; Isidor B; Jacquemont ML; Khau Van Kien P; Lacombe D; Martin L; Martinovic J; Maruani A; Mathieu-Dramard M; Mazereeuw-Hautier J; Michot C; Mignot C; Miquel J; Morice-Picard F; Petit F; Phan A; Rossi M; Touraine R; Verloes A; Vincent M; Vincent-Delorme C; Whalen S; Willems M; Marle N; Lehalle D; Thevenon J; Thauvin-Robinet C; Hadj-Rabia S; Faivre L; Vabres P; Rivière JB
Genet Med; 2017 Sep; 19(9):989-997. PubMed ID: 28151489
[TBL] [Abstract][Full Text] [Related]
14. [PIK3CA-related overgrowth syndrome (PROS)].
Venot Q; Canaud G
Nephrol Ther; 2017 Apr; 13 Suppl 1():S155-S156. PubMed ID: 28577738
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA mutation testing as a valuable molecular surrogate for lipomatosis of the median nerve: clinicopathological and molecular analysis of six cases.
Osterloh J; Agaimy A; Fried F; Stoehr R; Janka R; Arkudas A; Horch RE
Virchows Arch; 2023 Jul; 483(1):33-39. PubMed ID: 37067587
[TBL] [Abstract][Full Text] [Related]
16. Facial infiltrating lipomatosis: expression of angiogenic and vasculogenic factors.
Couto RA; Mulliken JB; Padwa BL; Hassanein AH; Rogers GF; Kulungowski AM; Greene AK
J Craniofac Surg; 2011 Nov; 22(6):2405-8. PubMed ID: 22134293
[TBL] [Abstract][Full Text] [Related]
17. An investigation of PIK3CA mutations in isolated macrodactyly.
Wu J; Tian W; Tian G; Sumner K; Hutchinson DT; Ji Y
J Hand Surg Eur Vol; 2018 Sep; 43(7):756-760. PubMed ID: 29661094
[TBL] [Abstract][Full Text] [Related]
18. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome.
Kurek KC; Luks VL; Ayturk UM; Alomari AI; Fishman SJ; Spencer SA; Mulliken JB; Bowen ME; Yamamoto GL; Kozakewich HP; Warman ML
Am J Hum Genet; 2012 Jun; 90(6):1108-15. PubMed ID: 22658544
[TBL] [Abstract][Full Text] [Related]
19. CD10 and CD34 as markers in vascular malformations with PIK3CA and TEK mutations.
Moneghini L; Tosi D; Graziani D; Caretti A; Colletti G; Baraldini V; Cattaneo E; Spaccini L; Zocca A; Bulfamante GP
Hum Pathol; 2020 May; 99():98-106. PubMed ID: 32272124
[TBL] [Abstract][Full Text] [Related]
20. Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations.
Brouillard P; Schlögel MJ; Homayun Sepehr N; Helaers R; Queisser A; Fastré E; Boutry S; Schmitz S; Clapuyt P; Hammer F; Dompmartin A; Weitz-Tuoretmaa A; Laranne J; Pasquesoone L; Vilain C; Boon LM; Vikkula M
Orphanet J Rare Dis; 2021 Jun; 16(1):267. PubMed ID: 34112235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
